Thrombophlebitis and "Enavid."

Name: Thrombophlebitis and "Enavid."
Creator: Ian S. Staddon
Keywords: 3. Good health

descriptionPublicationkeyboard_double_arrow_right Article 29 Sep 1962 English Publisher:BMJJournal:BMJ, volume 2, pages 857-857 (issn: 0959-8138, eissn: 1468-5833,

Authors: Ian S. Staddon;

doi: 10.1136/bmj.2.5308.857-b

Thrombophlebitis and "Enavid."

- Summary
- Related research
  (3)
- Metrics

Abstract

Sir I should like to report a case of thrombophlebitis in a patient taking "enavid". A married womam aged 38 suffering from dysmenorrhoea and endometriosis started taking enavid 5 mg t.d.s. on May 24 1962. On May 28 she developed phlebitis in a superficial vein on her left leg. The drug was stopped and there was no further extension of thrombosis. This patient had had phlebitis some years previously.(FULL TEXT)

3 Research products, page 1 of 1

Contraception and Thrombophlebitis
1962IsAmongTopNSimilarDocuments
The Excretion of Pregnanediol During Treatment with Gestagens (Enavid®) Estimated by Thin‐Layer‐Chromatography
1964IsAmongTopNSimilarDocuments
INHIBITION OF LACTOGENESIS BY COMBINED ORAL PROGESTOGENS AND ŒSTROGENS
1963IsAmongTopNSimilarDocuments

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average